JP2006514610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514610A5 JP2006514610A5 JP2004528184A JP2004528184A JP2006514610A5 JP 2006514610 A5 JP2006514610 A5 JP 2006514610A5 JP 2004528184 A JP2004528184 A JP 2004528184A JP 2004528184 A JP2004528184 A JP 2004528184A JP 2006514610 A5 JP2006514610 A5 JP 2006514610A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- compound
- halogen
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 58
- 150000001875 compounds Chemical class 0.000 claims 49
- 239000000203 mixture Substances 0.000 claims 31
- 125000003118 aryl group Chemical group 0.000 claims 29
- 125000000217 alkyl group Chemical group 0.000 claims 28
- 229910052736 halogen Inorganic materials 0.000 claims 27
- 150000002367 halogens Chemical class 0.000 claims 27
- 125000003545 alkoxy group Chemical group 0.000 claims 26
- 125000003710 aryl alkyl group Chemical group 0.000 claims 26
- 125000003342 alkenyl group Chemical group 0.000 claims 18
- 125000005842 heteroatom Chemical group 0.000 claims 18
- 125000005188 oxoalkyl group Chemical group 0.000 claims 18
- 229920000642 polymer Polymers 0.000 claims 18
- 239000000758 substrate Substances 0.000 claims 11
- 239000000412 dendrimer Substances 0.000 claims 10
- 229920000736 dendritic polymer Polymers 0.000 claims 10
- 239000002777 nucleoside Substances 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 9
- 208000015181 infectious disease Diseases 0.000 claims 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 5
- 230000032770 biofilm formation Effects 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 4
- 239000000835 fiber Substances 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 201000003883 Cystic fibrosis Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- -1 amine azide Chemical class 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 230000003373 anti-fouling effect Effects 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000000919 ceramic Substances 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 239000012024 dehydrating agents Substances 0.000 claims 2
- 208000002925 dental caries Diseases 0.000 claims 2
- 239000000551 dentifrice Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000011521 glass Substances 0.000 claims 2
- 210000003709 heart valve Anatomy 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000000178 monomer Substances 0.000 claims 2
- 239000002324 mouth wash Substances 0.000 claims 2
- 229940051866 mouthwash Drugs 0.000 claims 2
- 230000003287 optical effect Effects 0.000 claims 2
- 239000000123 paper Substances 0.000 claims 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 claims 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- 239000002023 wood Substances 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010069918 Bacterial prostatitis Diseases 0.000 claims 1
- 206010061695 Biliary tract infection Diseases 0.000 claims 1
- 206010051548 Burn infection Diseases 0.000 claims 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 206010011409 Cross infection Diseases 0.000 claims 1
- 241000238424 Crustacea Species 0.000 claims 1
- 241000195493 Cryptophyta Species 0.000 claims 1
- 208000036828 Device occlusion Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010028885 Necrotising fasciitis Diseases 0.000 claims 1
- 206010029803 Nosocomial infection Diseases 0.000 claims 1
- 206010031252 Osteomyelitis Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 1
- 206010048038 Wound infection Diseases 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 150000008360 acrylonitriles Chemical class 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 125000005103 alkyl silyl group Chemical group 0.000 claims 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000002519 antifouling agent Substances 0.000 claims 1
- 238000009360 aquaculture Methods 0.000 claims 1
- 244000144974 aquaculture Species 0.000 claims 1
- 239000002473 artificial blood Substances 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 150000007860 aryl ester derivatives Chemical class 0.000 claims 1
- 239000003899 bactericide agent Substances 0.000 claims 1
- 239000003139 biocide Substances 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 208000003167 cholangitis Diseases 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 239000012459 cleaning agent Substances 0.000 claims 1
- 239000008199 coating composition Substances 0.000 claims 1
- 239000005515 coenzyme Substances 0.000 claims 1
- 239000004567 concrete Substances 0.000 claims 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical class C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 230000018044 dehydration Effects 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 210000003298 dental enamel Anatomy 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical group O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 claims 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 206010014665 endocarditis Diseases 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000010440 gypsum Substances 0.000 claims 1
- 229910052602 gypsum Inorganic materials 0.000 claims 1
- 230000003699 hair surface Effects 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 229920000592 inorganic polymer Polymers 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000002608 ionic liquid Substances 0.000 claims 1
- 239000004579 marble Substances 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 210000004379 membrane Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000011490 mineral wool Substances 0.000 claims 1
- 239000002808 molecular sieve Substances 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 229920003052 natural elastomer Polymers 0.000 claims 1
- 229920001194 natural rubber Polymers 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 201000007970 necrotizing fasciitis Diseases 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 230000003606 oligomerizing effect Effects 0.000 claims 1
- 229920000620 organic polymer Polymers 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 230000000399 orthopedic effect Effects 0.000 claims 1
- 239000003973 paint Substances 0.000 claims 1
- 210000003695 paranasal sinus Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 210000003899 penis Anatomy 0.000 claims 1
- 201000001245 periodontitis Diseases 0.000 claims 1
- 206010034674 peritonitis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 229920003023 plastic Polymers 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- 229910052573 porcelain Inorganic materials 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 239000011435 rock Substances 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 229920003051 synthetic elastomer Polymers 0.000 claims 1
- 229920003002 synthetic resin Polymers 0.000 claims 1
- 239000000057 synthetic resin Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 239000004753 textile Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229920001187 thermosetting polymer Polymers 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 239000002966 varnish Substances 0.000 claims 1
- 239000003981 vehicle Substances 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002950862A AU2002950862A0 (en) | 2002-08-19 | 2002-08-19 | Furanone derivatives and methods of making same |
| PCT/AU2003/001053 WO2004016588A1 (en) | 2002-08-19 | 2003-08-19 | Furanone derivatives and methods of making same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514610A JP2006514610A (ja) | 2006-05-11 |
| JP2006514610A5 true JP2006514610A5 (enExample) | 2006-06-22 |
Family
ID=27809947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004528184A Pending JP2006514610A (ja) | 2002-08-19 | 2003-08-19 | フラノン誘導体およびその製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050215772A1 (enExample) |
| EP (1) | EP1539692A4 (enExample) |
| JP (1) | JP2006514610A (enExample) |
| CN (1) | CN1688543A (enExample) |
| AU (1) | AU2002950862A0 (enExample) |
| CA (1) | CA2495784A1 (enExample) |
| WO (1) | WO2004016588A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2545271A1 (en) * | 2003-12-05 | 2005-06-16 | Biosignal Limited | Association of antimicrobial compounds with surfaces and polymers |
| CA2596480A1 (en) * | 2005-02-04 | 2006-08-10 | Wisconsin Alumni Research Foundation | Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| JP4969065B2 (ja) * | 2005-07-13 | 2012-07-04 | 株式会社 メドレックス | 常温性イオン性液体を含有する医薬組成物 |
| US9586901B2 (en) * | 2006-01-24 | 2017-03-07 | Unilever Plc | Lactams |
| AU2015200142B2 (en) * | 2006-01-24 | 2016-07-07 | Unilever Plc | Novel lactams |
| AU2007249679B2 (en) * | 2006-05-15 | 2012-11-01 | Covidien Lp | Furanone-initiated polymers |
| EP2018373A1 (en) * | 2006-05-15 | 2009-01-28 | Tyco Healthcare Group, LP | Furanone endcapped polymers |
| WO2008040097A1 (en) * | 2006-10-06 | 2008-04-10 | Biosignal Limited | Furanone compounds and lactam analogues thereof |
| MX2009005783A (es) | 2006-12-01 | 2009-10-28 | Laclede Inc | Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos. |
| EP2136800A4 (en) | 2007-03-19 | 2011-10-05 | Wisconsin Alumni Res Found | MODULATION OF BACTERIAL QUORUM DETECTION WITH SYNTHETIC LIGANDS |
| CN101503397B (zh) * | 2009-03-23 | 2012-07-18 | 暨南大学 | 卤代呋喃酮化合物及其在制备抗感染药物上的应用 |
| US8624063B2 (en) | 2009-06-30 | 2014-01-07 | Wisconsin Alumni Research Foundation | Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing |
| EP2425862B1 (de) * | 2010-09-07 | 2012-08-29 | Miele & Cie. KG | Verfahren zur Reinigung und thermischen Desinfektion von Spülgut |
| CN102002024B (zh) * | 2010-11-19 | 2012-10-10 | 吉首大学 | 3-芳基-4-芳氨基-2（5h）-呋喃酮型化合物及其制法和用途 |
| EP3345596B1 (en) | 2012-09-21 | 2021-01-20 | Rhode Island Hospital | Inhibitors of beta-hydrolase for treatment of cancer |
| BR112015017911B1 (pt) * | 2013-02-01 | 2021-03-02 | Unilever Ip Holdings B.V | composição antimicrobiana, método para produzir uma composição antimicrobiana e uso de uma composição antimicrobiana |
| WO2014183164A1 (en) * | 2013-05-17 | 2014-11-20 | Naresh Kumar | Dihydropyrrolones and their use as antimicrobial agents |
| WO2016176146A1 (en) * | 2015-04-26 | 2016-11-03 | The Trustees Of Princeton University | Surfaces comprising attached quorum sensing modulators |
| BR112018003173B1 (pt) | 2015-08-20 | 2021-12-14 | Nilever Ip Holdings B.V. | Lactama encapsulada, aditivo, composição e método de encapsulamento de uma lactama |
| US10888087B2 (en) | 2015-08-20 | 2021-01-12 | Conopco, Inc. | Lactam solubility |
| BR112018002983B1 (pt) * | 2015-08-20 | 2021-06-29 | Unilever Ip Holdings B.V. | Composição compreendendo uma lactama e um álcool |
| CN107920978A (zh) * | 2015-08-20 | 2018-04-17 | 荷兰联合利华有限公司 | 改善的内酰胺溶解度 |
| WO2017029112A1 (en) * | 2015-08-20 | 2017-02-23 | Unilever Plc | Lactam compositions |
| BR112018003074B1 (pt) | 2015-08-20 | 2021-07-13 | Unilever Ip Holdings B.V. | Composição compreendendo uma lactama e um biotensoativo de glicolipídeo |
| CN109475525A (zh) | 2016-07-21 | 2019-03-15 | 荷兰联合利华有限公司 | 4-(4-氯苯基)-5-亚甲基-吡咯-2-酮和5-亚甲基-4-(对甲苯基)吡咯-2-酮用于治疗革兰氏阴性细菌感染 |
| WO2018015279A1 (en) * | 2016-07-21 | 2018-01-25 | Unilever Plc | Lactams for the treatment of respiratory tract infections |
| US11083706B2 (en) | 2016-07-21 | 2021-08-10 | Conopco, Inc. | Lactams for use in the treatment of skin lesions |
| CN106518818B (zh) * | 2016-10-14 | 2018-07-27 | 宁波大学 | 一种呋喃酮类化合物及其制备方法和用途 |
| BR112019010110A2 (pt) | 2016-11-17 | 2019-08-20 | Unilever Nv | composição de lactama e uso da composição farmacêutica |
| CN109862788A (zh) | 2016-11-17 | 2019-06-07 | 荷兰联合利华有限公司 | 内酰胺组合物 |
| US10526278B2 (en) | 2017-10-19 | 2020-01-07 | Wisconsin Alumni Research Foundation | Inhibitors of quorum sensing receptor LasR |
| RU2691634C2 (ru) * | 2017-11-27 | 2019-06-17 | Федеральное Государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт мясного скотоводства | СПОСОБ ПРИМЕНЕНИЯ ГАММА-ОКТАЛАКТОНА В КАЧЕСТВЕ ИНГИБИТОРА СИСТЕМЫ "КВОРУМ СЕНСИНГА" LuxI/LuxR ТИПА У БАКТЕРИЙ |
| CN109705068A (zh) * | 2019-02-27 | 2019-05-03 | 重庆医药高等专科学校 | 原白头翁素合成方法 |
| CN115667424A (zh) * | 2020-04-21 | 2023-01-31 | 联合利华知识产权控股有限公司 | 清漆 |
| CN115884997B (zh) * | 2020-06-23 | 2023-12-22 | 阿克佐诺贝尔国际涂料股份有限公司 | 可辐射固化的涂料组合物、涂覆基材的方法和经涂覆的基材 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3755356A (en) * | 1969-11-06 | 1973-08-28 | Zoecon Corp | Substituted crotonic amide ypsilon-lactams |
| AUPM666694A0 (en) * | 1994-07-06 | 1994-07-28 | Unisearch Limited | Natural antifouling compositions |
| AUPQ841900A0 (en) * | 2000-06-28 | 2000-07-20 | Unisearch Limited | Synthesis of cyclic compounds |
-
2002
- 2002-08-19 AU AU2002950862A patent/AU2002950862A0/en not_active Abandoned
-
2003
- 2003-08-19 EP EP03787526A patent/EP1539692A4/en not_active Withdrawn
- 2003-08-19 CN CNA038243997A patent/CN1688543A/zh active Pending
- 2003-08-19 WO PCT/AU2003/001053 patent/WO2004016588A1/en not_active Ceased
- 2003-08-19 CA CA002495784A patent/CA2495784A1/en not_active Abandoned
- 2003-08-19 JP JP2004528184A patent/JP2006514610A/ja active Pending
- 2003-08-19 US US10/525,231 patent/US20050215772A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514610A5 (enExample) | ||
| US9586901B2 (en) | Lactams | |
| CN102947237B (zh) | 抗微生物剂涂覆的医学制品 | |
| JP5752051B2 (ja) | バイオフィルム除去用抗菌性組成物およびその使用 | |
| CA2647325C (en) | Methods and systems for preparing antimicrobial bridged polycyclic compounds | |
| JP2006514610A (ja) | フラノン誘導体およびその製造方法 | |
| US20100221308A1 (en) | Antimicrobial compositions and uses thereof | |
| US9591848B2 (en) | Biofilm resistant polymer materials | |
| JP2010509467A (ja) | ウイルス及び細菌を不活化するポリマーコーティング | |
| KR20190000903A (ko) | 자가 오염제거 표면을 형성하기 위한 조성물 및 방법 | |
| CN115209903B (zh) | 组合物及其用途 | |
| JP2001510197A (ja) | 水安定化オルガノシラン化合物およびその使用 | |
| CN112841222B (zh) | 一种抗菌杀毒材料及应用 | |
| JP2000159608A (ja) | 抗菌性組成物 | |
| US20120276040A1 (en) | Antimicrobial compositions and methods of making same | |
| US20250143307A1 (en) | Graftable biocidal linkers and polymers and uses thereof | |
| EP2009031B1 (en) | Antimicrobial compositions and methods of making same | |
| Schinabeck et al. | Biofilm-related indwelling medical device infections | |
| JP2010006809A (ja) | 抗菌剤の組成およびその製造の方法。 | |
| JP7717797B2 (ja) | 抗菌ペプチド又はペプチド誘導体、置換体及びその組成物、製造方法及び応用 | |
| WO2025196442A1 (en) | Antimicrobial compounds | |
| JP2004532108A (ja) | 抗菌性ポリマー表面 | |
| JPH11322770A (ja) | 水安定化オルガノシラン化合物及びそれを用いる方法 | |
| AU2015200142A1 (en) | Novel lactams | |
| WO2024097204A1 (en) | Graftable biocidal linkers and polymers and uses thereof |